Updated Jul 16, 2026
SASSINE ANDY is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $20K.
Andy Sassine is the Chief Financial Officer and a Director at Arcturus Therapeutics Holdings Inc., a company focused on RNA medicines and vaccine development. He has also held similar roles at ICAD INC.
| Role | Chief Financial Officer, Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-08-15 | ARCT | Arcturus Therapeutics Holdings Inc. | P — Open-market purchase | 1.2K | $16.56 | $20K |
| 2025-07-17 | ICAD | ICAD INC | D — Derivative transaction | 1.20M | — |
Andy Sassine is the Chief Financial Officer and a Director at Arcturus Therapeutics Holdings Inc., a company focused on RNA medicines and vaccine development. He has also held similar roles at ICAD INC.…
Recorded transactions: 1 open-market purchases ($20K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live SASSINE ANDY profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.